NCCN Panel Digs Into Reality of CAR T-cell Reimbursement
(AJMC.com Managed Markets Network) Mar 21, 2019 - A panel during the opening day of the 2019 National Comprehensive Cancer Network Annual Conference examined the recent process for National Coverage Determination for chimeric antigen receptor (CAR) T-cell therapy and what it means for the future of innovative treatments.